ReShape Lifesciences shares are trading higher after the company received a Notice of Allowance for its U.S. patent application titled "Intragastric Volume-Occupying Device and Method for Fabricating Same" for treating obesity.
Portfolio Pulse from Benzinga Newsdesk
ReShape Lifesciences shares are trading higher after the company received a Notice of Allowance for its U.S. patent application titled 'Intragastric Volume-Occupying Device and Method for Fabricating Same' for treating obesity.
July 03, 2024 | 5:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
ReShape Lifesciences shares are trading higher following the receipt of a Notice of Allowance for its U.S. patent application for an obesity treatment device.
The Notice of Allowance for the patent application is a significant milestone for ReShape Lifesciences, indicating that the patent will likely be granted. This development is likely to boost investor confidence and drive the stock price higher in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100